Literature DB >> 10381587

Evidence for phosphorylation-dependent internalization of recombinant human rho1 GABAC receptors.

N Filippova1, R Dudley, D S Weiss.   

Abstract

1. Recombinant wild-type or mutant human rho1 GABA receptors were expressed in human embryonic kidney (HEK) 293 or monkey COS-7 cells and studied using the patch clamp technique. 2. Standard whole-cell recordings with 4 mM Mg-ATP in the patch pipette induced a time-dependent decrease in the GABA-activated current (IGABA) amplitude that was not the result of a decrease in GABA sensitivity. In contrast, IGABA remained stable when recordings were obtained using the perforated patch configuration or with standard whole-cell recording and no Mg-ATP in the patch pipette. 3. The inhibitors of serine/threonine protein kinases KN-62 (20 microM) or staurosporine (20 nM) prevented the time-dependent decrease in the amplitude of IGABA seen in the presence of ATP. Alkaline phosphatase (220 U ml-1), when added to the patch pipette in the absence of ATP, induced a transient potentiation of IGABA. Although the protein kinase C (PKC) activator 4beta-phorbol 12-myristate, 13-acetate (PMA) did not reduce the amplitude of IGABA, inclusion of the catalytic domain of PKC in the recording pipette accelerated the time-dependent decrease in current amplitude. These data suggest that phosphorylation is involved in the regulation of the amplitude of IGABA. 4. Mutation of the three PKC consensus sequences of the rho1 receptor had no significant effect on the decline in IGABA, indicating that direct phosphorylation of these putative sites on the rho1 receptor does not underlie the time-dependent decrease in amplitude. 5. In COS-7 cells transfected with wild-type rho1 receptors, the amplitude of IGABA had completely recovered to the original value when the same cells were repatched after 30-40 min, indicating that the decline in IGABA was a reversible process. 6. The inhibitor of actin filament formation cytochalasin B, when added to the patch pipette in the absence of ATP, induced a time-dependent inactivation suggesting that the actin cytoskeleton may play a role in the regulation of the amplitude. 7. Coincident with the decrease in the amplitude of IGABA, the cell capacitance significantly decreased in the presence of ATP in the patch pipette. This decrease in capacitance was not observed in the absence of Mg-ATP. The decrease in the membrane surface area suggests that receptor internalization could be a potential mechanism for the observed inactivation. 8. At 32 C, compared with 22 C, the rate and magnitude of the decline was increased dramatically. In contrast, at 16 C, no significant change in IGABA was observed over the 20 min recording time. This marked temperature sensitivity is consistent with receptor internalization as a mechanism for the time-dependent decline in IGABA. 9. The specificity of the decrease in IGABA was assessed by coexpressing the voltage-dependent potassium channel Kv1.4 along with the rho1 receptor in HEK293 cells. The amplitude of the potassium current (IKv1.4) exhibited very little decrement in comparison to IGABA suggesting that the putative GABA receptor internalization was not the consequence of a non-specific membrane retrieval.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10381587      PMCID: PMC2269426          DOI: 10.1111/j.1469-7793.1999.0385p.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  51 in total

1.  Adjacent phosphorylation sites on GABAA receptor beta subunits determine regulation by cAMP-dependent protein kinase.

Authors:  B J McDonald; A Amato; C N Connolly; D Benke; S J Moss; T G Smart
Journal:  Nat Neurosci       Date:  1998-05       Impact factor: 24.884

Review 2.  Brain spectrin, calpain and long-term changes in synaptic efficacy.

Authors:  G Lynch; M Baudry
Journal:  Brain Res Bull       Date:  1987-06       Impact factor: 4.077

3.  Patch-clamp techniques for time-resolved capacitance measurements in single cells.

Authors:  M Lindau; E Neher
Journal:  Pflugers Arch       Date:  1988-02       Impact factor: 3.657

Review 4.  Endocytosis.

Authors:  S C Silverstein; R M Steinman; Z A Cohn
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

Review 5.  Actin and actin-binding proteins. A critical evaluation of mechanisms and functions.

Authors:  T D Pollard; J A Cooper
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

Review 6.  Calcium and the cytoskeleton.

Authors:  J Bennett; A Weeds
Journal:  Br Med Bull       Date:  1986-10       Impact factor: 4.291

7.  "Run-down" of gamma-aminobutyric acidA receptor function during whole-cell recording: a possible role for phosphorylation.

Authors:  M Gyenes; M Farrant; D H Farb
Journal:  Mol Pharmacol       Date:  1988-12       Impact factor: 4.436

8.  GABAA-receptor function in hippocampal cells is maintained by phosphorylation factors.

Authors:  A Stelzer; A R Kay; R K Wong
Journal:  Science       Date:  1988-07-15       Impact factor: 47.728

9.  Activation of protein kinase C differentially modulates neuronal Na+, Ca2+, and gamma-aminobutyrate type A channels.

Authors:  E Sigel; R Baur
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

10.  Role of the cytoskeleton in the formation, stabilization, and removal of acetylcholine receptor clusters in cultured muscle cells.

Authors:  J A Connolly
Journal:  J Cell Biol       Date:  1984-07       Impact factor: 10.539

View more
  14 in total

1.  Recombinant GABA(C) receptors expressed in rat hippocampal neurons after infection with an adenovirus containing the human rho1 subunit.

Authors:  N Filippova; A Sedelnikova; W J Tyler; T L Whitworth; H Fortinberry; D S Weiss
Journal:  J Physiol       Date:  2001-08-15       Impact factor: 5.182

2.  Regulation of somatodendritic GABAA receptor channels in rat hippocampal neurons: evidence for a role of the small GTPase Rac1.

Authors:  D K Meyer; C Olenik; F Hofmann; H Barth; J Leemhuis; I Brünig; K Aktories; W Nörenberg
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

3.  Kinetic properties of GABA rho1 homomeric receptors expressed in HEK293 cells.

Authors:  Jay Yang; Qing Cheng; Ayako Takahashi; Farida Goubaeva
Journal:  Biophys J       Date:  2006-06-23       Impact factor: 4.033

4.  Activation of the tonic GABAC receptor current in retinal bipolar cell terminals by nonvesicular GABA release.

Authors:  S M Jones; M J Palmer
Journal:  J Neurophysiol       Date:  2009-06-03       Impact factor: 2.714

Review 5.  GABA-ρ receptors: distinctive functions and molecular pharmacology.

Authors:  Moawiah M Naffaa; Sandy Hung; Mary Chebib; Graham A R Johnston; Jane R Hanrahan
Journal:  Br J Pharmacol       Date:  2017-04-12       Impact factor: 8.739

6.  Hypoxia-induced silencing of NMDA receptors in turtle neurons.

Authors:  P E Bickler; P H Donohoe; L T Buck
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

7.  Suppression of neuronal hyperexcitability and associated delayed neuronal death by adenoviral expression of GABA(C) receptors.

Authors:  Q Cheng; J C Kulli; J Yang
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

8.  Assembly of alpha4beta2 nicotinic acetylcholine receptors assessed with functional fluorescently labeled subunits: effects of localization, trafficking, and nicotine-induced upregulation in clonal mammalian cells and in cultured midbrain neurons.

Authors:  Raad Nashmi; Mary E Dickinson; Sheri McKinney; Mark Jareb; Cesar Labarca; Scott E Fraser; Henry A Lester
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

9.  Mechanisms of homomeric alpha1 glycine receptor endocytosis.

Authors:  Renqi Huang; Shaoqing He; Zhenglan Chen; Glenn H Dillon; Nancy J Leidenheimer
Journal:  Biochemistry       Date:  2007-09-22       Impact factor: 3.162

10.  Streptozotocin-induced diabetes modulates GABA receptor activity of rat retinal neurons.

Authors:  David J Ramsey; Harris Ripps; Haohua Qian
Journal:  Exp Eye Res       Date:  2007-06-19       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.